Circulating cell-free DNA in serum as a biomarker of colorectal cancer

Journal of Clinical Pathology

Volumn 66, Issue 9, 2013, Pages 775-778

  Da Silva Filho, Benisio Ferreira ^a   Gurgel, Ana Pavla Almeida Diniz ^b   De Freitas Lins Neto, Manoel Álvaro ^a   De Azevedo, Dalmo Almeida ^a   De Freitas, Antonio Carlos ^b   Da Costa Silva Neto, Jacinto ^b   Silva, Luiz Antonio Ferreira ^a  

^a FEDERAL UNIVERSITY OF ALAGOAS   (Brazil)

^b FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CIRCULATING CELL FREE DNA; DNA FRAGMENT; FIBRINOGEN; GENOMIC DNA; LIPOPROTEIN LIPASE; TAQ POLYMERASE; TUMOR MARKER; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER STAGING; COLORECTAL CARCINOMA; CONTROLLED STUDY; GENE SEQUENCE; HUMAN; HUMAN TISSUE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

COLORECTAL CANCER; MOLECULAR PATHOLOGY; PCR;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; COLORECTAL NEOPLASMS; DNA; FEMALE; HUMANS; MALE; MICROSATELLITE REPEATS; MIDDLE AGED;

EID: 84882861857     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jclinpath-2013-201521     Document Type: Article

References (32)

1. Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin 2011;61:69-90.
2. Vogelstein B, Fearon ER, Hamilton SR, et al. Genetic alterations during colorectal-tumor development. N Engl J Med 1988;319:525-32.
3. Vogelstein B, Kinzler KW. Cancer genes and the pathways they control. Nat Med 2004;10:789-99.
4. Pritchard CC, Grady WM. Colorectal cancer molecular biology moves into clinical practice. Gut 2011;60:116-29.
5. Huerta S. Recent advances in the molecular diagnosis and prognosis of colorectal cancer. Expert Rev Mol Diagn 2008;8:277-88.
6. Lieberman DA. Clinical practice. Screening for colorectal cancer. N Engl J Med 2009;361:1179-87.
7. Van der Vaart M, Pretorius PJ. A method for characterization of total circulating DNA. Ann N Y Acad Sci 2008;1137:92-7.
8. Jing R-R, Wang H-M, Cui M, et al. A sensitive method to quantify human cell-free circulating DNA in blood: relevance to myocardial infarction screening. Clin Biochem 2011;44:1074-9.
9. Hauser S, Zahalka T, Ellinger J, et al. Cell-free Circulating DNA: diagnostic value in patients with renal cell cancer. Anticancer Res 2010;30:2785-9.
10. Ellinger J, Wittkamp V, Albers P, et al. Cell-free circulating DNA: diagnostic value in patients with testicular germ cell cancer. J Urol 2009;181:363-71.
11. Yu M, Wan YF, Zou QH. Cell-free circulating mitochondrial DNA in the serum: A potential non-invasive biomarker for Ewing's sarcoma. Arch Med Res 2012 Jul;43 (5):389-94.
12. Kohler C, Barekati Z, Radpour R, et al. Cell-free DNA in the Circulation as a Potential Cancer Biomarker. Anticancer Res 2011;31:2623-2628.
13. Pathak AK, Bhutani M, Kumar S, et al. Circulating cell-free DNA in plasma/serum of lung cancer patients as a potential screening and prognostic tool. Clinical Chemistry 2006;52:1833-42.
14. Paci M, Maramotti S, Bellesia E, et al. Circulating plasma DNA as diagnostic biomarker in non-small cell lung cancer. Lung Cancer 2009;64:92-7.
15. Mead R, Duku M, Bhandari P, et al. Circulating tumour markers can define patients with normal colons, benign polyps, and cancers. Br J Cancer 2011;105:239-45.
16. Page K, Hava N, Ward B, et al. Detection of HER2 amplification in circulating free DNA in patients with breast cancer. Br J Cancer 2011;104:1342-8.
17. Ha TTN, Huy NT, Murao LA, et al. Elevated levels of cell-free circulating DNA in patients with acute dengue virus infection. PLoS ONE 2011;6:e25969.
18. Boni L, Cassinotti E, Canziani M, et al. Free circulating DNA as possible tumour marker in colorectal cancer. Surg Oncol 2007;16:29-31.
19. Shaw JA, Page K, Blighe K, et al. Genomic analysis of circulating cell-free DNA infers breast cancer dormancy. Genome Research 2012 Feb;22(2):220-31.
20. Umetani N, Kim J, Hiramatsu S, et al. Increased integrity of free circulating DNA in sera of patients with colorectal or periampullary cancer: direct quantitative PCR for ALU repeats. Clin Chem 2006;52:1062-9.
21. Umetani N, Giuliano AE, Hiramatsu SH, et al. Prediction of breast tumor progression by integrity of free circulating DNA in serum. JCO 2006;24:4270-6.
22. Casoni GL, Ulivi P, Mercatali L, et al. Increased levels of free circulating DNA in patients with idiopathic pulmonary fibrosis. Int J Biol Markers 2010;25:229-35.
23. Board RE, Williams VS, Knight L, et al. Isolation and extraction of circulating tumor DNA from patients with small cell lung cancer. Ann N Y Acad Sci 2008;1137:98-107.
24. Zachariah RR, Schmid S, Buerki N, et al. Levels of circulating cell-free nuclear and mitochondrial DNA in benign and malignant ovarian tumors. Obstet Gynecol 2008;112:843-50.
25. Czeiger D, Shaked G, Eini H, et al. Measurement of circulating cell-free DNA levels by a new simple fluorescent test in patients with primary colorectal cancer. Am J Clin Pathol 2011;135:264-70.
26. Catarino R, Ferreira MM, Rodrigues H, et al. Quantification of free circulating tumor DNA as a diagnostic marker for breast cancer. DNA Cell Biol 2008;27:415-21.
27. Sunami E, Vu A-T, Nguyen SL, et al. Quantification of LINE1 in Circulating DNA as a Molecular Biomarker of Breast Cancer. Ann N Y Acad Sci 2008;1137:171-4.
28. Gordian E, Ramachandran K, Reis IM, et al. Serum free circulating DNA is a useful biomarker to distinguish benign versus malignant prostate disease. Cancer Epidemiol Biomarkers Prev 2010;19:1984-91.
29. Bastian PJ, Palapattu GS, Yegnasubramanian S, et al. Prognostic value of preoperative serum cell-free circulating DNA in men with prostate cancer undergoing radical prostatectomy. Clin Cancer Res 2007;13:5361-7.
30. Frattini M, Gallino G, Signoroni S, et al. Quantitative analysis of plasma DNA in colorectal cancer patients: A novel prognostic tool. Ann N Y Acad Sci 2006;1075:185-90.
31. Agostini M, Pucciarelli S, Enzo MV, et al. Circulating cell-free DNA: A promising marker of pathologic tumor response in rectal cancer patients receiving preoperative chemoradiotherapy. Ann Surg Oncol 2011;18:2461-8.
32. Flamini E, Mercatali L, Nanni O, et al. Free DNA and carcinoembryonic antigen serum levels: An important combination for diagnosis of colorectal cancer. Clin Cancer Res 2006;12:6985-8.